Tonsillectomy with or without adenoidectomy is one of the most frequently performed surgical procedures in children 1, 2 . Untreated children undergoing tonsillectomy are at high risk for postoperative nausea and vomiting (PONV), which occurs with an incidence of 26 to 89% [3] [4] [5] [6] [7] .
Accordingly, there is a need for drugs and techniques that minimise PONV.
McCollum et al reported that propofol has significant antiemetic activity at subhypnotic doses 8 and many anaesthesiologists use it because of this property 9 . Subhypnotic propofol infusion has been used successfully to manage chemotherapy-induced emesis 10 . Continuous infusion of subhypnotic propofol prevented PONV in female patients receiving intravenous patient-controlled analgesia 11 .
Serotonin type 3 (5-HT 3 ) receptor antagonists, such as ondansetron, granisetron and tropisetron, have been shown to reduce the incidence of PONV in children 4, 6, 7, 12, 13 . Jensen et al showed that tropisetron was significantly more effective than placebo in controlling emesis during the first 24 hours after tonsillectomy 7 . Postoperative therapies combining 5-HT 3 receptor antagonists with other drugs have SUMMARY This study evaluated the efficacy of tropisetron compared with tropisetron and a subhypnotic propofol infusion in preventing postoperative vomiting following tonsillectomy. One hundred and forty healthy children, aged four to 12 years, undergoing tonsillectomy were recruited in a randomised, double-blind study. After induction with sevoflurane, anaesthesia was maintained with sevoflurane and nitrous oxide. All patients received tropisetron (0.2 mg/kg up to 5 mg; intravenously) and fentanyl (2 µg/kg; intravenously) and were intubated after atracurium which was reversed with neostigmine (and atropine). The tropisetron-plus-propofol group received a single dose of propofol (1 mg/kg) before intubation and a continuous infusion of propofol throughout surgery at 15 µg/kg/min. Data for postoperative vomiting were grouped into zero to four and four to 24 hour time intervals. A P value of <0.05 was considered statistically significant.
The percentage of patients exhibiting a complete response (no retching or vomiting for 24 hours) was 47.1% (33/70) in the tropisetron-alone group and 72.8% (51/70) in the tropisetron-plus-propofol group (P=0.002). The 0.257 absolute risk reduction of vomiting with the addition of propofol represents a number needed to treat of 3.87, and a risk ratio of 0.51 (95% CI 0.32 to 0.79). Significantly fewer patients vomited in the tropisetron-plus-propofol group than in the tropisetron-alone group during the zero to four post-surgery interval (P=0.016), but the difference was not statistically significant for the four to 24 hour postoperative period (P=0.116). Intraoperative subhypnotic propofol infusion combined with tropisetron is more effective than tropisetron alone in reducing postoperative vomiting after tonsillectomy in children.
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Anaesthesia and Intensive Care, Vol. 37, No. 1, January 2009 been evaluated and shown to yield additive antiemetic effects, including following tonsillectomy 6,14-17 .
To date, no studies have explored the efficacy of subhypnotic infusion doses of propofol intraoperatively added to tropisetron for prevention of postoperative vomiting in either paediatric or tonsillectomy surgical populations. The purpose of this prospective, randomised and double-blind study was to compare the effect of tropisetron with combining tropisetron with intraoperative subhypnotic propofol infusion during surgery on postoperative vomiting in children undergoing tonsillectomy.
MATERiAlS AND METHODS
One hundred and forty inpatient children, four to 12 years old with an ASA physical status of i or ii, who were undergoing tonsillectomy with or without adenoidectomy were enrolled in the study. Written parental consent was obtained for each participating child and the study was approved by the Medical Ethics Committee of Ataturk University School of Medicine. The study was designed as a prospective, randomised and double-blind trial; only the anaesthetist, who did not participate in data collection/analysis, knew which therapy was administered. Children with systemic disease, history of motion sickness, those receiving antiemetic, antihistamine or steroid drugs within 24 hours prior to surgery, or those with allergies to any of the drugs to be used were excluded from the study. Patients undergoing any surgery in addition to tonsillectomy with or without adenoidectomy were also excluded. The patients and parents were informed of the two different study groups, but were not told to which group the child would be assigned.
Patients were required to fast from milk and solids for six hours prior to surgery. Clear fluids were allowed up to three hours before surgery was expected to begin. Before anaesthesia induction, patients were randomly assigned to the following study groups using a sealed envelope technique: tropisetronalone (n=70) or tropisetron-plus-propofol (n=70). Standard ASA monitors were placed and all patients received a standardised anaesthetic protocol. Without any premedication, anaesthesia was induced by inhalation of sevoflurane (7 to 8% via a face mask) and maintained with 2 to 3% sevoflurane and 35% oxygen in nitrous oxide. After establishment of intravenous access, fentanyl (2 µg/kg) and atracurium besylate (0.5 mg/kg) was administered. Atropine (0.02 mg/kg) and neostigmine (0.06 mg/kg) were administered to reverse muscle relaxation. Patients in both groups received 0.2 mg/kg tropisetron (up to a total of 5 mg) before intubation. Patients in the tropisetron-plus-propofol group received 1 mg/kg propofol before intubation. Propofol was then administered continuously during surgery at the rate of 15 µg/kg/min. A sharp dissection tonsillectomy technique was performed on all patients. To control bleeding, bipolar cauterisation or suture ligation, when needed, was performed. At the end of the surgery and prior to extubation, stomach contents were emptied. After extubation, the patients were transferred to the post-anaesthesia care unit and followed for two hours before being transferred to the Department of Otolaryngology.
Intravenous fluid (Ringer's lactate) management was standard and included intraoperative fluid maintenance and the replacement of fluid deficits in cases with insufficient oral fluid intake. Oral fluids were offered four hours post-surgery and if fluid intake was insufficient, Ringer's lactate was continued and fluid was offered again two hours later.
The children subsequently received 1500 ml/m 2 /24 h until they were capable of sufficient oral intake.
A doctor blinded to the study groups noted the vomiting experience of the patients. Vomiting, rather than nausea, was documented because in our experience nausea is difficult to assess in children.
Retching was also recorded because it is readily assessed and constitutes an unpleasant experience comparable to vomiting. Reports of vomiting were obtained through interviews with the parent and child. Data for postoperative vomiting were grouped into zero to four and four to 24 hour time periods. When retching or vomiting occurred more than twice in 30 minutes, metoclopramide (0.15 mg/kg intravenously) was administered as a rescue antiemetic. Complete responses, defined as no retching or vomiting during the 24-hour period following tonsillectomy, were also documented. For postoperative analgesia, paracetamol (20 to 30 mg/kg) was given rectally or orally four times on the day of surgery. The first dose was administered rectally in the post-anaesthesia care unit. Subsequent doses were administered according to each child's ability to tolerate oral liquids.
Data collected for all patients included gender, age, weight, duration of anaesthesia (time from induction of anaesthesia to endotracheal extubation), duration of surgery (time from surgery start to the end of bleeding control), vomiting, presence or absence of a complete response and rescue antiemetic requirements.
We considered the proportion of the patients who exhibited a complete response (defined as no retching or vomiting for 24 hours) as the primary outcome. Power analysis determined that 70 patients in each group would be needed to detect a 30% difference in the number of the patients with no vomiting for 24 hours postoperatively with a power (1-β) of 0.8 (α=0.05). The proportion of the patients with no vomiting during the zero to four hours and four to 24 hour periods and the need for rescue antiemetic were considered as secondary outcomes.
Statistical analysis of the data was performed using the Statistical Package for Social Sciences 15.0 software for Windows (SPSS inc., Chicago, il, USA). A Student's t-test was used to compare parametric data, including demographic characteristics, anaesthesia and operation time. A Chi-squared test was used for frequency comparisons. P values less than 0.05 were considered to be statistically significant. The data are presented as means ± SD. STATA 10 (CollegeStation, Texas, USA) was used to calculate the risk ratio for the primary outcomes, absolute risk reduction and the numbers needed to treat.
RESUlTS
One hundred and forty patients were enrolled in the study. All subjects were included in the analysis. There were no significant differences between the groups with respect to age, gender, weight and duration of anaesthesia or surgery (Table 1) .
There was strong evidence for less vomiting in the tropisetron-plus-propofol versus tropisetron-alone groups ( Table 2) . A complete response, defined as no retching or vomiting for 24 hours after tonsillectomy, occurred in 51/70 patients (72.9%) in the tropisetronplus-propofol group and in 33/70 patients (47.2%) in the tropisetron-alone group (P=0.002). This 49% reduction in risk of vomiting with the addition of propofol represents a risk ratio of 0.51 (95% Ci 0.32 to 0.79). The absolute risk reduction of 0.257 represents a number needed to treat of 3.87. There was good evidence that propofol-plus-tropisetron is associated with less vomiting than tropisetronalone within the first four hours, while there was no evidence for a difference in the four to 24 hour period ( Table 2 ). Patients receiving tropisetron-alone had an incidence of vomiting of 42.8% during the first four hours and this incidence was reduced to 24.2% in the tropisetron-plus-propofol group (P=0.016). The number of patients who experienced vomiting during the four to 24 hour period was 20/70 in the tropisetron-alone group and 13/70 in the tropisetronplus-propofol group (P=0.116). Twelve patients in the tropisetron-alone group and six patients in the tropisetron-plus-propofol group received Values are expressed as number (n) or mean (±SD). Values are expressed as number (n) and percentage in parentheses.
metoclopramide as a rescue antiemetic during the postoperative period. This difference between the two groups did not reach statistical significance (P=0.103), (Table 2) . For postoperative analgesia, all patients received rectal or oral paracetamol (20 to 30 mg/kg) four times on the day of surgery. Oral liquids were first offered four hours postoperatively. Twelve patients in the tropisetron-alone group could not tolerate fluids at this time; of these, eight were able to take fluids after six hours. in the tropisetron-plus-propofol group, three patients were unable to tolerate oral liquids at four hours, but only one was unable to take fluids after six hours. All patients were able to take fluids eight hours after surgery. Ringer's lactate was given intravenously (1500 ml/m 2 /24 h) to patients unable to tolerate fluids postoperatively.
DiSCUSSiON
The present study suggests that propofol, when given at the beginning of anaesthesia and continued throughout surgery as a subhypnotic infusion dose, improves the antiemetic effect of tropisetron after tonsillectomy in children.
The antiemetic action of propofol has been evaluated by McCollum et al 8 and also by Borgeat et al 18 , who reported that propofol possessed direct antiemetic properties. The basis of propofol's antiemetic action has not been thoroughly resolved, although the release of excitatory amino acids such as glutamate and aspartate may be involved 19 . gan et al suggested several other mechanisms for the antiemetic action of propofol, including direct depressant effects on the chemoreceptor trigger zone, the vagal nuclei and other centres implicated in nausea and vomiting 20 . A role for an antidopaminergic pathway in the antiemetic action of propofol, postulated by DiFlorio 21 , has since been refuted by two studies 19, 22 . in the present study, adding a subhypnotic propofol infusion to tropisetron treatment during surgery increased both the number of patients who experienced no vomiting during the zero to four hour interval and the number of patients exhibiting a complete response. The precise mechanism by which addition of the subhypnotic propofol infusion to tropisetron increased protection against postoperative vomiting remains unknown. It is likely that the combination of tropisetron with subhypnotic propofol infusion results in synergistic antiemetic effects following tonsillectomy.
A subhypnotic dose (17 µg/kg/min) of propofol provided excellent antiemetic action after cancer chemotherapy 23 . zestos et al investigated the efficacy of a subhypnotic dose of propofol to treat vomiting after adenotonsillectomy 24 . in this study, patients with retching or vomiting after surgery who were given a single subhypnotic dose 0.2 mg/kg of propofol fared no better than patients receiving a placebo. A subsequent study by Gan et al 25 found that the plasma concentration of propofol needed to effectively manage postoperative nausea and vomiting was 343 ng/ml, and concluded that a bolus dose of 10 mg followed by an infusion of approximately 10 µg/kg/min was necessary to achieve this antiemetic plasma concentration. Because the concentration of propofol would be expected to fall below the therapeutic concentration after a very low bolus dose, in retrospect, the absence of an antiemetic effect in the study of zestos et al is not surprising. To ensure that therapeutic levels of propofol were maintained in our study, we administered a bolus dose of propofol followed by an infusion of 15 µg/kg/min. Propofol, when administered to induce and maintain anaesthesia, is more effective than ondansetron in preventing postoperative vomiting, but when used only as an induction agent or for induction and also at the end of surgery, is not as protective against PONV 20 . Total intravenous anaesthesia with propofol results in a clinicallyrelevant reduction in PONV compared with isoflurane-nitrous oxide anaesthesia 26 . Continuous infusion of subhypnotic propofol prevented PONV in female patients receiving intravenous patientcontrolled analgesia 11 . The 1.0 mg/kg/h subhypnotic propofol dose has been found to reduce the incidence of post-delivery nausea and vomiting in women undergoing caesarean delivery, without causing excessive sedation. Furthermore, this dose of propofol exhibits greater antiemetic efficiency than do traditional antiemetics (metoclopramide and droperidol) 27 .
Intravenous tropisetron had been used for prophylaxis, but the incidence of postoperative vomiting was still quite high, ranging from 29 to 55%, after tonsillectomy 7,28,29 . Tropisetron plus dexamethasone was shown to be more effective than tropisetron alone in reducing the incidence of postoperative nausea and vomiting following tonsillectomy 6 . A 0.15 mg/kg bolus of dexamethasone in combination with tropisetron, compared to tropisetron alone, considerably reduced the incidence of vomiting from 53.3 to 24.4% in children following adenotonsillectomy 16 . in our study the percentage of patients without vomiting in the first 24 hours after tonsillectomy was 47.1% in the tropisetron-alone group and 72.8% without vomiting when a subhypnotic propofol infusion during surgery was added to tropisetron.
Only one prophylactic antiemetic agent may not be sufficient to prevent PONV in high-risk patients. Performing a minimum of two antiemetic interventions with different mechanisms of action is considered standard practice for children undergoing tonsillectomy 30 . The use of propofol as an antiemetic has been recommended by consensus guidelines for managing postoperative nausea and vomiting 31 . it is also important to ensure good intravenous hydration to avoid hypotension, provide effective analgesia and employ combinations of antiemetic agents 9 . in our study, the patients were closely monitored to ensure adequate intravenous hydration during surgery and in the immediate-postoperative period (routinely for a minimum of four hours), or until each patient was able to tolerate sufficient oral intake of liquids. All patients also received a carefully administered, standardised analgesia regimen, including fentanyl during surgery with rectal or oral paracetamol after surgery. Consideration should be made to repeating this study excluding nitrous oxide and using double agent antiemetics to determine if the incidence of vomiting associated with the additional subhypnotic propofol technique might be further reduced.
in conclusion, for children undergoing tonsillectomy in this study, adding a subhypnotic propofol infusion with a rate of 15 µg/kg/min intraoperatively to 0.15 mg/kg tropisetron was more effective than tropisetron alone for reducing postoperative vomiting.
